CCN2 and early-onset autosomal dominant Alzheimer disease: Here, the decreased fibrosis was associated with decreased CTGF expression in the TUDCA-TAC group (Fig 5), similar to a previous study showing decreases in CTGF level by TUDCA treatment in a mouse model of Alzheimer’s disease [28].